Findings

What do systematic reviews say?

24 questions · 24 findings · 6 reviews · Kidney and Transplant

No studies found 3 · 12.5%GRADE not reported 0 · 0%Very low 9 · 37.5%Low 9 · 37.5%Moderate 3 · 12.5%High 0 · 0%

Discontinuation of medication due to adverse events · people with diabetes and CKD

1 finding from 1 review

Discontinuation of medication due to adverse events · people with diabetes and CKD

1 finding from 1 review

Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 551 participants
Very low

Discontinuation of medication due to adverse events · people with diabetes and CKD

1 finding from 1 review

Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 917 participants
Very low

Withdrawals due to adverse events · anaemia in predialysis patients

Epoetin theta showed no clear difference in adverse events: discontinuation of therapy compared with epoetin beta (low certainty).

1 finding from 1 review

Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes only
RR 1.77 [0.68, 4.63]
1 study · 288 participants
Low